PMC:7341831 / 3917-4176
Annnotations
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T7 | 119-123 | Body_part | denotes | tube | http://purl.obolibrary.org/obo/UBERON_0000025 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
118 | 4-11 | Species | denotes | patient | Tax:9606 |
120 | 21-32 | Chemical | denotes | oseltamivir | MESH:D053139 |
121 | 57-68 | Chemical | denotes | chloroquine | MESH:D002738 |
122 | 128-140 | Chemical | denotes | azithromycin | MESH:D017963 |
123 | 158-169 | Chemical | denotes | ceftriaxone | MESH:D002443 |
124 | 183-193 | Chemical | denotes | furosemide | MESH:D005665 |
125 | 236-246 | Chemical | denotes | enoxaparin | MESH:D017984 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T28 | 105-106 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T29 | 119-123 | http://purl.obolibrary.org/obo/UBERON_0000025 | denotes | tube |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T36 | 21-32 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
T37 | 57-68 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T38 | 125-127 | Chemical | denotes | IV | http://purl.obolibrary.org/obo/CHEBI_74327 |
T39 | 128-140 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
T40 | 155-157 | Chemical | denotes | IV | http://purl.obolibrary.org/obo/CHEBI_74327 |
T41 | 158-169 | Chemical | denotes | ceftriaxone | http://purl.obolibrary.org/obo/CHEBI_29007 |
T42 | 180-182 | Chemical | denotes | IV | http://purl.obolibrary.org/obo/CHEBI_74327 |
T43 | 183-193 | Chemical | denotes | furosemide | http://purl.obolibrary.org/obo/CHEBI_47426 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T36 | 0-259 | Sentence | denotes | The patient received oseltamivir (75 mg twice daily) and chloroquine (450 mg twice on the first day) via a nasoenteral tube, IV azithromycin (500 mg/day), IV ceftriaxone (2g/day), IV furosemide (20mg TID), and prophylactic subcutaneous enoxaparin (40 mg/day). |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T55 | 21-32 | CHEBI:7798;CHEBI:7798 | denotes | oseltamivir |
T56 | 57-68 | CHEBI:3638;CHEBI:3638;DG_10 | denotes | chloroquine |
T57 | 128-140 | CHEBI:2955;CHEBI:2955;DG_6 | denotes | azithromycin |
T58 | 158-169 | CHEBI:29007;CHEBI:29007 | denotes | ceftriaxone |
T59 | 183-193 | CHEBI:47426;CHEBI:47426 | denotes | furosemide |
T24320 | 21-32 | CHEBI:7798;CHEBI:7798 | denotes | oseltamivir |
T83491 | 57-68 | CHEBI:3638;CHEBI:3638;DG_10 | denotes | chloroquine |
T9292 | 128-140 | CHEBI:2955;CHEBI:2955;DG_6 | denotes | azithromycin |
T19984 | 158-169 | CHEBI:29007;CHEBI:29007 | denotes | ceftriaxone |
T4490 | 183-193 | CHEBI:47426;CHEBI:47426 | denotes | furosemide |